Fabhalta Side Effects
Generic name: iptacopan
Note: This document contains side effect information about iptacopan. Some dosage forms listed on this page may not apply to the brand name Fabhalta.
Applies to iptacopan: oral capsule.
Warning
You may get infections more easily, even serious or fatal infections. Call your doctor if you have flu symptoms, cough, night sweats, neck stiffness, confusion, or vision problems.
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
You may get infections more easily, even serious or fatal infections. Call your doctor right away if you have signs of infection such as:
-
fever, chills, sore throat;
-
mouth sores, red or swollen gums;
-
pale skin, easy bruising, unusual bleeding;
-
chest discomfort, wheezing, dry cough or hack, rapid weight loss; or
-
symptoms of meningitis--headache, neck stiffness, increased sensitivity to light, nausea, vomiting, confusion, drowsiness.
Your condition may get worse if you stop taking this medicine. If you stop using iptacopan (the active ingredient contained in Fabhalta) tell your doctor if you have any new or worsening symptoms, such as tiredness, confusion, stomach pain, trouble breathing or swallowing, blood in your urine, difficulty having an erection, chest pain, pain in one leg, or numbness or weakness on one side of the body.
Common side effects may include:
-
headache;
-
infections caused by bacteria or virus;
-
cold symptoms such as stuffy nose, sneezing, sore throat;
-
rash; or
-
diarrhea, nausea, stomach pain.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to iptacopan: oral capsule.
General
The most common adverse effects observed in more than 10% patients were headache, nasopharyngitis, diarrhea, abdominal pain, bacterial infection, viral infection, nausea, and rash.
Cardiovascular
Common (1% to 10%): Systemic hypertension[Ref]
Dermatologic
Common (1% to 10%): Rash, urticaria
Rash included allergic dermatitis, acne, multiforme erythema, maculopapular rash, and erythematous rash.
Gastrointestinal
Very common (10% or more): Abdominal pain (up to 15%), diarrhea (up to 15%)
Common (1% to 10%): Nausea
Hematologic
Very common (10% or more): Thrombocytopenia (up to 43%)
Metabolic
Very common (10% or more): Hypercholesterolemia (up to 43%), increased low-density lipoprotein (LDL)-cholesterol (up to 17%), serum triglyceride (up to 27%)
Common (1% to 10%): Lipid disorder
Lipid disorder included dyslipidemia, increased blood cholesterol, increased LDL, hypercholesterolemia, increased blood triglycerides, and hyperlipidemia.
Musculoskeletal
Common (1% to 10%): Arthralgia
Nervous system
Very common (10% or more): Headache (up to 28%)
Common (1% to 10%): Dizziness
Other
Very common (10% or more): Bacterial infection (up to 11%), viral infection (up to 18%)
Bacterial infection included pyelonephritis, urinary tract infection, bacterial bronchitis, Haemophilus bronchitis, cholecystitis, folliculitis, cellulitis, bacterial arthritis, sepsis, Klebsiella infection, staphylococcal infection, Pseudomonas infection, hordeolum, and bacterial pneumonia.
Viral infection included COVID-19, herpes zoster, oral herpes, nasal herpes, influenza A virus test positive, and influenza.
Respiratory
Very common (10% or more): Nasopharyngitis (up to 16%)
Nasopharyngitis included allergic rhinitis, upper respiratory tract infection, pharyngitis, and rhinitis.
More about Fabhalta (iptacopan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- En español
Patient resources
Professional resources
Related treatment guides
References
1. Product Information. Fabhalta (iptacopan). Novartis Pharmaceuticals. 2023;ORIG-1.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.